These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6231191)

  • 1. Depo-Provera: the jury still out.
    Gold RB
    Fam Plann Perspect; 1983; 15(2):78-81. PubMed ID: 6231191
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depo-Provera: a critical analysis.
    Minkin S
    Women Health; 1980; 5(2):49-69. PubMed ID: 6451987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medroxyprogesterone (Depo Provera) and breast cancer.
    McCowan L
    N Z Med J; 1990 May; 103(889):225-6. PubMed ID: 2140436
    [No Abstract]   [Full Text] [Related]  

  • 5. Depo Provera and breast cancer.
    McCowan L; Farquhar C; Roke C; Liddell H; Roberts H; Thakurdas N; Wilson J; Say PJ; McClure F
    N Z Med J; 1991 Jan; 104(904):16-7. PubMed ID: 1826144
    [No Abstract]   [Full Text] [Related]  

  • 6. Depo-Provera: new developments in a decade-old controversy.
    Gold RB; Willson PD
    Fam Plann Perspect; 1981; 13(1):35-9. PubMed ID: 6452287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depo-Provera. Controversial contraceptive wins approval from FDA panel.
    Stone R
    Science; 1992 Jun; 256(5065):1754. PubMed ID: 1535454
    [No Abstract]   [Full Text] [Related]  

  • 10. Depo-Provera--ethical issues in its testing and distribution.
    Potts M; Paxman JM
    J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovulation inhibitors and tumors].
    Freundl G; Brossmann H
    Dtsch Med Wochenschr; 1985 Aug; 110(35):1346-50. PubMed ID: 3896722
    [No Abstract]   [Full Text] [Related]  

  • 12. Depo-provera in the First World.
    McDonough RT
    Hastings Cent Rep; 1988; 18(4):44-5. PubMed ID: 2975641
    [No Abstract]   [Full Text] [Related]  

  • 13. Contraceptives and cancer--looking for the evidence.
    Cent Afr J Med; 1992 Feb; 38(2):88-9. PubMed ID: 1387044
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contraception using 3-monthly injections of Depo-Provera].
    Revaz C; Welti H; Dettling A
    Gynakol Rundsch; 1978; 18(3-4):183-92. PubMed ID: 569623
    [No Abstract]   [Full Text] [Related]  

  • 15. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
    Richard BW; Lasagna L
    Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Depo-Provera.
    Sapire KE
    S Afr Med J; 1992 May; 81(9):444-5. PubMed ID: 1533472
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing times for women in body lab.
    Bacon W
    Lamp; 1983 May; 40(3):38-40. PubMed ID: 6228701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns voiced on Depo Provera.
    Sanders C
    RNAO News; 1986; 42(3):15, 22. PubMed ID: 2940668
    [No Abstract]   [Full Text] [Related]  

  • 20. The Depo-Provera public hearing.
    Dening FC
    Midwives Chron; 1983 Jul; 96(1146):246. PubMed ID: 6225940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.